Holdings
iShares Neuroscience and Healthcare ETF
As of Jul 31, 2026, iShares Neuroscience and Healthcare ETF reported 66 positions worth US$5.24M. Largest: Dianthus Therapeutics, Inc., Xenon Pharmaceuticals Inc. and Praxis Precision Medicines, Inc. What it bought and sold, with each filing.
Holdings
- Part of
- BlackRock
- Positions
- 66
- Value as reported
- US$5.24M
- Holdings as of
- Jul 31, 2026
- Last filed
- Sep 23, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. NASDAQ:DNTH | 2,739 | US$293K | 5.3% | +741 | Jul 31, 2026 |
| Xenon Pharmaceuticals Inc. NASDAQ:XENE | 4,264 | US$267K | 4.9% | −155 | Jul 31, 2026 |
| Praxis Precision Medicines, Inc. NASDAQ:PRAX | 868 | US$267K | 4.9% | +274 | Jul 31, 2026 |
| ACADIA Pharmaceuticals Inc. NASDAQ:ACAD | 9,949 | US$257K | 4.7% | +1,621 | Jul 31, 2026 |
| Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR | 3,016 | US$255K | 4.7% | −87 | Jul 31, 2026 |
| Alkermes plc NASDAQ:ALKS | 5,153 | US$252K | 4.6% | −1,293 | Jul 31, 2026 |
| Scholar Rock Holding Corporation NASDAQ:SRRK | 4,979 | US$235K | 4.3% | +904 | Jul 31, 2026 |
| Biogen Inc. NASDAQ:BIIB | 1,129 | US$229K | 4.2% | +125 | Jul 31, 2026 |
| Neurocrine Biosciences, Inc. NASDAQ:NBIX | 1,345 | US$224K | 4.1% | −103 | Jul 31, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | 3,109 | US$211K | 3.9% | +171 | Jul 31, 2026 |
| Axsome Therapeutics, Inc. NASDAQ:AXSM | 949 | US$207K | 3.8% | −195 | Jul 31, 2026 |
| Denali Therapeutics Inc. NASDAQ:DNLI | 8,750 | US$201K | 3.7% | +950 | Jul 31, 2026 |
| Dyne Therapeutics, Inc. NASDAQ:DYN | 7,764 | US$195K | 3.6% | +798 | Jul 31, 2026 |
| Edgewise Therapeutics, Inc. NASDAQ:EWTX | 4,615 | US$177K | 3.2% | +383 | Jul 31, 2026 |
| Supernus Pharmaceuticals, Inc. NASDAQ:SUPN | 3,202 | US$143K | 2.6% | +202 | Jul 31, 2026 |
| Axogen, Inc. NASDAQ:AXGN | 3,041 | US$128K | 2.3% | +241 | Jul 31, 2026 |
| SK Biopharmaceuticals Co., Ltd. KRX:326030 | 2,295 | US$126K | 2.3% | +748 | Jul 31, 2026 |
| H. Lundbeck A/S Class A OMXCOP:HLUN_A | 15,754 | US$101K | 1.8% | +992 | Jul 31, 2026 |
| Biohaven Ltd. NYSE:BHVN | 7,377 | US$99,590 | 1.8% | +361 | Jul 31, 2026 |
| Sarepta Therapeutics, Inc. NASDAQ:SRPT | 5,954 | US$88,476 | 1.6% | +474 | Jul 31, 2026 |
| BioArctic AB Class B OMXSTO:BIOA_B | 2,506 | US$85,563 | 1.6% | +480 | Jul 31, 2026 |
| Taysha Gene Therapies, Inc. NASDAQ:TSHA | 13,999 | US$82,034 | 1.5% | +1,630 | Jul 31, 2026 |
| Neuren Pharmaceuticals Limited ASX:NEU | 6,435 | US$81,113 | 1.5% | +419 | Jul 31, 2026 |
| Idorsia Ltd. SIX:IDIA | 10,423 | US$78,965 | 1.4% | +858 | Jul 31, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | 1,673 | US$68,560 | 1.2% | +63 | Jul 31, 2026 |
| Integra LifeSciences Holdings Corporation NASDAQ:IART | 3,915 | US$65,185 | 1.2% | +240 | Jul 31, 2026 |
| Alto Neuroscience, Inc. NYSE:ANRO | 1,846 | US$49,971 | 0.91% | +275 | Jul 31, 2026 |
| LB Pharmaceuticals Inc NASDAQ:LBRX | 1,221 | US$48,938 | 0.89% | +185 | Jul 31, 2026 |
| Dynavox Group AB OMXSTO:DYVOX | 5,818 | US$43,886 | 0.80% | +367 | Jul 31, 2026 |
| Annexon, Inc. NASDAQ:ANNX | 8,380 | US$42,696 | 0.78% | +1,332 | Jul 31, 2026 |
| MedinCell SA EURONEXT:MEDCL | 1,372 | US$41,256 | 0.75% | +217 | Jul 31, 2026 |
| Solid Biosciences Inc. NASDAQ:SLDB | 4,599 | US$37,068 | 0.68% | +1,297 | Jul 31, 2026 |
| Bright Minds Biosciences Inc. CSE:DRUG | 445 | US$32,601 | 0.59% | −94 | Jul 31, 2026 |
| Relmada Therapeutics, Inc. NASDAQ:RLMD | 5,416 | US$28,759 | 0.52% | +2,082 | Jul 31, 2026 |
| Design Therapeutics, Inc. NASDAQ:DSGN | 2,215 | US$26,979 | 0.49% | +471 | Jul 31, 2026 |
| Regenxbio Inc. NASDAQ:RGNX | 2,749 | US$26,638 | 0.49% | +217 | Jul 31, 2026 |
| Oncolys BioPharma, Inc. TSE:4588 | 1,600 | US$26,307 | 0.48% | +200 | Jul 31, 2026 |
| CeriBell, Inc. NASDAQ:CBLL | 1,447 | US$25,597 | 0.47% | +110 | Jul 31, 2026 |
| Neurogene Inc. NASDAQ:NGNE | 740 | US$24,339 | 0.44% | +62 | Jul 31, 2026 |
| ClearPoint Neuro Inc. NASDAQ:CLPT | 1,572 | US$23,486 | 0.43% | +154 | Jul 31, 2026 |
| Benitec Biopharma Inc. NASDAQ:BNTC | 1,981 | US$23,198 | 0.42% | +183 | Jul 31, 2026 |
| Prothena Corporation plc NASDAQ:PRTA | 2,759 | US$22,403 | 0.41% | +367 | Jul 31, 2026 |
| Ovid Therapeutics Inc. NASDAQ:OVID | 9,777 | US$21,705 | 0.40% | +3,413 | Jul 31, 2026 |
| MicroPort NeuroScientific Corporation HKEX:2172 | 19,000 | US$21,657 | 0.39% | +1,000 | Jul 31, 2026 |
| NeuroPace, Inc. NASDAQ:NPCE | 1,543 | US$19,889 | 0.36% | +145 | Jul 31, 2026 |
| SanBio Co., Ltd. TSE:4592 | 3,400 | US$19,555 | 0.36% | +200 | Jul 31, 2026 |
| Zylox-Tonbridge Medical Technology Co., Ltd. Class H HKEX:2190 | 8,000 | US$19,417 | 0.35% | −1,000 | Jul 31, 2026 |
| Vanda Pharmaceuticals Inc. NASDAQ:VNDA | 3,342 | US$17,044 | 0.31% | +346 | Jul 31, 2026 |
| Newron Pharmaceuticals S.p.A. SIX:NWRN | 1,060 | US$15,362 | 0.28% | +69 | Jul 31, 2026 |
| Anavex Life Sciences Corp. NASDAQ:AVXL | 5,343 | US$14,693 | 0.27% | +400 | Jul 31, 2026 |
| Peijia Medical Ltd. HKEX:9996 | 28,000 | US$14,313 | 0.26% | +2,000 | Jul 31, 2026 |
| Santhera Pharmaceuticals Holding AG SIX:SANN | 771 | US$13,512 | 0.25% | +115 | Jul 31, 2026 |
| Inhibikase Therapeutics, Inc. NASDAQ:IKT | 5,679 | US$12,380 | 0.23% | +599 | Jul 31, 2026 |
| Capricor Therapeutics, Inc. NASDAQ:CAPR | 3,077 | US$11,846 | 0.22% | +384 | Jul 31, 2026 |
| Larimar Therapeutics, Inc. NASDAQ:LRMR | 3,008 | US$11,491 | 0.21% | +727 | Jul 31, 2026 |
| Tonix Pharmaceuticals Holding Corp. NASDAQ:TNXP | 953 | US$9,540 | 0.17% | +265 | Jul 31, 2026 |
| Voyager Therapeutics, Inc. NASDAQ:VYGR | 3,080 | US$9,332 | 0.17% | +566 | Jul 31, 2026 |
| Entrada Therapeutics, Inc. NASDAQ:TRDA | 1,328 | US$9,017 | 0.16% | +150 | Jul 31, 2026 |
| AC Immune SA NASDAQ:ACIU | 3,783 | US$8,285 | 0.15% | +433 | Jul 31, 2026 |
| Acumen Pharmaceuticals, Inc. NASDAQ:ABOS | 3,768 | US$8,101 | 0.15% | +1,213 | Jul 31, 2026 |
| Alector, Inc. NASDAQ:ALEC | 4,762 | US$7,191 | 0.13% | +654 | Jul 31, 2026 |
| Neumora Therapeutics, Inc. NASDAQ:NMRA | 4,388 | US$7,065 | 0.13% | +1,328 | Jul 31, 2026 |
| Myung In Pharm Co., Ltd. KRX:317450 | 212 | US$6,241 | 0.11% | +1 | Jul 31, 2026 |
| PepGen Inc. NASDAQ:PEPG | 3,476 | US$6,118 | 0.11% | +120 | Jul 31, 2026 |
| MapLight Therapeutics, Inc. NASDAQ:MPLT | 445 | US$5,794 | 0.11% | −232 | Jul 31, 2026 |
| Cognition Therapeutics, Inc. NASDAQ:CGTX | 4,543 | US$4,041 | 0.07% | +200 | Jul 31, 2026 |